Navigation Links
ACNP: Novel NMDA receptor modulator significantly reduces depression scores within hours
Date:12/6/2012

HOLLYWOOD, FL and EVANSTON, IL, December 6, 2012 -- Naurex Inc., a clinical stage company developing innovative treatments to address unmet needs in psychiatry and neurology, today reported positive results from a Phase IIa clinical trial of its lead antidepressant compound, GLYX-13. GLYX-13 is a novel partial agonist of the NMDA receptor. The Phase Ila results are being presented this week at the 51st Annual Meeting of the American College of Neuropsychopharmacology (ACNP).

The Phase IIa results show that a single administration of GLYX-13 produced statistically significant reductions in depression scores in subjects who had failed treatment with one or more antidepressant agents. The reductions were evident within 24 hours and persisted for an average of seven days. Importantly, the effect size, a measure of the magnitude of the drug's antidepressant efficacy, observed at 24 hours and at seven days after a single administration of GLYX-13, was nearly double the effect size seen with most other antidepressant drugs after 4-6 weeks of repeated dosing.

In the Phase IIa trial, GLYX-13 was well tolerated. Reported side effects were mild to moderate and were consistent with those observed in subjects receiving placebo. Consistent with previous studies, GLYX-13 did not produce any of the schizophrenia-like psychotomimetic effects associated with other drugs that modulate the NMDA receptor.

"These data are an important step in validating Naurex's mission of developing breakthrough therapies for depression and other CNS disorders," said Derek Small, CEO of Naurex. "Our founder discovered a new class of drugs that appeared to have the remarkable antidepressant efficacy of ketamine-like compounds, but without their limiting side effects. These Phase II results suggest that this discovery may translate into measurable health improvements for individuals with depression, which bodes well for the future success of GLYX-13 and the other p
'/>"/>

Contact: Barbara Lindheim
blindheim@bllbiopartners.com
917-355-9234
BLL Partners, LLC
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Scripps Florida scientists uncover a novel cooperative effort to stop cancer spread
2. Novel mechanism through which normal stromal cells become cancer-promoting cells identified
3. Novel breast screening technology increases diagnostic accuracy
4. UNC, Vanderbilt discover a new live vaccine approach for SARS and novel coronaviruses
5. Moffitt Cancer Center researchers identify novel metabolic programs driving aggressive brain tumors
6. Novel treatment strategies for epilepsy
7. Taiho Pharmaceutical unveils data on 8 novel anticancer compounds
8. Researchers ID potential patient population who may benefit from novel anti-platelet treatment
9. Undertreatment of common heart condition persists despite rapid adoption of novel therapies
10. Moffitt cancer center researchers find novel predictor for MDS progression risk
11. Novel surgery removes rare tumor, rebuilds face and jaw
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/16/2014)... (PRWEB) September 16, 2014 The ... Management practice by Ranking Arizona magazine, has selected ... across its enterprise. , With TPC seeing hundreds ... vast data repository that was managed through “home grown” ... the management and clinical leadership teams. “Our current ...
(Date:9/16/2014)... September 16, 2014 Synergy Research Group ... report gives the best detail and analysis of the ... from a variety of sources, including Ministry of Health ... Paper will give readers actionable intelligence on clinical trials ... is relied on by the local and international life ...
(Date:9/16/2014)... 2014 Whatisfinalexpenseinsurance.com has released a ... affordable life insurance for seniors. , Finding affordable life ... A big part of the insurance market has moved ... tips that clients can use when shopping for life ... is important for providing financial security for vulnerable family ...
(Date:9/16/2014)... comparison of five-year sexual function outcomes, as ... radiotherapy (EBRT) versus combination EBRT plus brachytherapy, ... therapy makes cure possible without compromising long-term ... at the American Society for Radiation Oncology,s ... study examined the patient-reported outcomes of 91 ...
(Date:9/16/2014)... San Francisco, September 16, 2014A large, international analysis of ... indicates that a patient,s overall survival (OS) rate can ... metastases develop and lymph node involvement, and that aggressive ... rate of 47.8 percent, according to research presented today ... Annual Meeting. , When lung cancer has spread ...
Breaking Medicine News(10 mins):Health News:The Pain Center of Arizona (TPC) Implements Analance™ BI for Actionable Intelligence 2Health News:The Pain Center of Arizona (TPC) Implements Analance™ BI for Actionable Intelligence 3Health News:Synergy Research Group Debuts Ukraine Orange Paper 2Health News:Life Insurance for Seniors - Clients Can Find Fast Life Insurance By Comparing Online Quotes! 2Health News:Prostate cancer patients surveyed 5 years after vessel-sparing RT report preserved sexual function 2Health News:Prostate cancer patients surveyed 5 years after vessel-sparing RT report preserved sexual function 3Health News:Select group of stage IV lung cancer patients achieve long-term survival after aggressive treatments 2Health News:Select group of stage IV lung cancer patients achieve long-term survival after aggressive treatments 3Health News:Select group of stage IV lung cancer patients achieve long-term survival after aggressive treatments 4
... LONDON, NEW YORK, NORWICH, England and ONGAR, Ireland,Sept. 4 ... announced on the 29th August that it has acquired ... and Safety Monitor was launched at the same time ... and has tracked the developing,legislation since then. It has ...
... Off September,s Ovarian Cancer Awareness ... ... Cancer,Coalition (NOCC) launched its newest educational initiative, Eva,s Divas,with a celebrity red-carpet ... the first to pledge to empower and educate,women nationwide about the symptoms ...
... Inc. (Amex:,ULU) today announced that it is scheduled ... at 3:15 p.m. Eastern Time on Thursday,September 4, ... is an emerging specialty pharmaceutical company focused on,the ... surgery and,oral care products to provide patients and ...
... women are always in search,of easy diets that will help ... have become a little too snug for comfort. Celebrity style,expert ... their,jeans and how they can get their hands on actual ... (See video from Kellogg,s at:, http://media.medialink.com/WebNR.aspx?story=35515 ) On ...
... juice is,thought to ward off HIV/AIDS. In others, homosexuality ... misinformation and stigma, how can,developing countries fight a virus ... Part of the answer is to enlist the power ... media development nonprofit that has,provided in-depth training and mentoring ...
... --- There,s no magic bullet for wiping out malaria, ... method that effectively delays the evolution of drug resistance ... , David Smith, associate director of disease ecology at ... scientists and policy makers in extending the longevity of ...
Cached Medicine News:Health News:Schofield Publishing Enters the Newsletter Market 2Health News:National Ovarian Cancer Coalition and CSI: Miami Star Eva La Rue Launch Eva's Divas in Hollywood to Educate Women Nationwide About Ovarian Cancer 2Health News:National Ovarian Cancer Coalition and CSI: Miami Star Eva La Rue Launch Eva's Divas in Hollywood to Educate Women Nationwide About Ovarian Cancer 3Health News:More than 1,000 Journalists Enlisted in Fight Against HIV/AIDS 2Health News:Study: Delaying evolution of drug resistance in malaria parasite possible 2Health News:Study: Delaying evolution of drug resistance in malaria parasite possible 3
(Date:9/16/2014)... , Sept. 16, 2014 CorMedix ... focused on developing and commercializing therapeutic products for ... infectious diseases, announces the amendment and restatement of ... preferred stock and related warrants, as well as ... stock and warrant financing, to remove anti-dilution, price ...
(Date:9/16/2014)... CALGARY, Alberta , Sept. 16, 2014 /PRNewswire/ ... $1.4 billion industry in less than two years, ... along the way. A huge opportunity exists for ... Today, Vivametrica ( http://vivametrica.com/our-video/ ) introduced a first-of-its-kind ... providers based on years of clinical research linking ...
(Date:9/16/2014)... , N.J. and NEW PROVIDENCE, N.J. ... experts will present a paper on the critical ... medical oxygen storage and deliver systems at the American ... will be held at the Chicago Sheraton Hotel and ... Derrick West , program manager of ...
Breaking Medicine Technology:CorMedix Amends and Restates Outstanding Securities to Remove Provisions Causing Derivative Liability Classification 2CorMedix Amends and Restates Outstanding Securities to Remove Provisions Causing Derivative Liability Classification 3Doctors Launch Initiative to Bridge Gap Between Wearables and Meaningful Health Data 2Doctors Launch Initiative to Bridge Gap Between Wearables and Meaningful Health Data 3Linde Healthcare experts to present details on installation of medical oxygen storage and distribution systems at ASPE convention 2Linde Healthcare experts to present details on installation of medical oxygen storage and distribution systems at ASPE convention 3
... 2012 Reportlinker.com announces that a ... in its catalogue: , ... Report & Forecast: 2011-2016 ... in antibody technology has revolutionized both ...
... Texas, Feb. 6, 2012 Luminex Corporation (NASDAQ: ... fourth quarter and year ended December 31, 2011.  Financial ... (Logo: http://photos.prnewswire.com/prnh/20100104/LUMINEXLOGO ) Consolidated fourth quarter ... over the fourth quarter of 2010; full-year 2011 revenue ...
Cached Medicine Technology:Indian Diagnostic & Therapeutic Antibodies Market Report & Forecast: 2011-2016 2Indian Diagnostic & Therapeutic Antibodies Market Report & Forecast: 2011-2016 3Indian Diagnostic & Therapeutic Antibodies Market Report & Forecast: 2011-2016 4Indian Diagnostic & Therapeutic Antibodies Market Report & Forecast: 2011-2016 5Indian Diagnostic & Therapeutic Antibodies Market Report & Forecast: 2011-2016 6Indian Diagnostic & Therapeutic Antibodies Market Report & Forecast: 2011-2016 7Luminex Corporation Reports Fourth Quarter and Full Year 2011 Results 2Luminex Corporation Reports Fourth Quarter and Full Year 2011 Results 3Luminex Corporation Reports Fourth Quarter and Full Year 2011 Results 4Luminex Corporation Reports Fourth Quarter and Full Year 2011 Results 5Luminex Corporation Reports Fourth Quarter and Full Year 2011 Results 6Luminex Corporation Reports Fourth Quarter and Full Year 2011 Results 7Luminex Corporation Reports Fourth Quarter and Full Year 2011 Results 8Luminex Corporation Reports Fourth Quarter and Full Year 2011 Results 9
Model 8097 is CSA Certified. Thermo Forma Plasma Freezers safely store single donor, fresh frozen plasma, and cryoprecipitate. Recorders are standard....
... complying with Australian Standard AS3864-1997 suitable to ... grey colorbond steel with a powder coated ... 40-litre capacity polished stainless steel compartment. Lid ... a heated top fascia. A removable chrome ...
... 1400 Series Biosafety Cabinets ... revolutionize working in a ... most comfortable, quiet, and ... cabinet on the market, ...
... 12 Holter Analysis Kit incorporates detection of ... other powerful DMS Holter analysis tools. Premier ... possible in less than 10 seconds and ... visual verification and validation. The TWA algorithm ...
Medicine Products: